SlideShare una empresa de Scribd logo
1 de 10
69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice  A workshop co-organised by MeTA (Medicine Transparence Aliance) and FIP FIP-WHO META Istanbul, Turkey  September 5, 2009
FIP-WHO META Istanbul, Turkey  September 5, 2009 Workshop objectives: 1. To inform FIP and interested Congress participants about the Medicines Transparency Alliance (MeTA) and its concept of transparency. 2. To discuss how transparency can be applied in pharmacy practice, especially in developing countries. 3. To strengthen professional links between MeTA and FIP.
Timetable ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009
69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice  GROUP AND PLENARY DISCUSSION  FIP-WHO META Istanbul, Turkey  September 5, 2009
3 QUESTIONS ,[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009
3 QUESTIONS ,[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009
3 QUESTIONS ,[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009
3 Questions: ,[object Object],[object Object],[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009
69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice   Panel Discussion FIP-WHO META Istanbul, Turkey  September 5, 2009
Panel Discusion ,[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],[object Object],FIP-WHO META Istanbul, Turkey  September 5, 2009

Más contenido relacionado

Similar a MeTA FIP workshop programme

Transparency and Pharmaceutical Practice from a MeTA Country
Transparency and Pharmaceutical Practice from a MeTA CountryTransparency and Pharmaceutical Practice from a MeTA Country
Transparency and Pharmaceutical Practice from a MeTA CountryMeTApresents
 
Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...MeTApresents
 
EFPIA Disclosure & Consent Management
EFPIA Disclosure & Consent ManagementEFPIA Disclosure & Consent Management
EFPIA Disclosure & Consent Managementqordata
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial SupplyAbdul Jamad
 
SMi Group's 8th annual Parallel Trade conference
SMi Group's 8th annual Parallel Trade conferenceSMi Group's 8th annual Parallel Trade conference
SMi Group's 8th annual Parallel Trade conferenceDale Butler
 
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation  Immunotherapy Europe - The Perfect Combination of Strategy and Innovation
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation Michael Adeniya
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015Market iT
 
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIESSUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIESRitwik Parikh
 
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...AmeetRathod3
 
European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016Harris John
 
European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016Fazmina Fajju
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the euGlobalCompliancePanel
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceDale Butler
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESHEALY LAD
 
Responsible practice in e vapour products (evp) product stewardship 2016
Responsible practice in e vapour products (evp) product stewardship 2016Responsible practice in e vapour products (evp) product stewardship 2016
Responsible practice in e vapour products (evp) product stewardship 2016Fontem Ventures
 
PIL January First Issue 2015
PIL January First Issue 2015PIL January First Issue 2015
PIL January First Issue 2015David Karenye
 

Similar a MeTA FIP workshop programme (20)

Transparency and Pharmaceutical Practice from a MeTA Country
Transparency and Pharmaceutical Practice from a MeTA CountryTransparency and Pharmaceutical Practice from a MeTA Country
Transparency and Pharmaceutical Practice from a MeTA Country
 
Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...Contribution of a world-class regulatory system to the future of the pharmace...
Contribution of a world-class regulatory system to the future of the pharmace...
 
Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...Skills interpreting data, understanding policy responses, communicating to th...
Skills interpreting data, understanding policy responses, communicating to th...
 
ICH PPT
ICH PPTICH PPT
ICH PPT
 
EFPIA Disclosure & Consent Management
EFPIA Disclosure & Consent ManagementEFPIA Disclosure & Consent Management
EFPIA Disclosure & Consent Management
 
CTSC 16
CTSC 16CTSC 16
CTSC 16
 
Clinical Trial Supply
Clinical Trial SupplyClinical Trial Supply
Clinical Trial Supply
 
IPU National Pharmacy Conference 2016
IPU National Pharmacy Conference 2016IPU National Pharmacy Conference 2016
IPU National Pharmacy Conference 2016
 
SMi Group's 8th annual Parallel Trade conference
SMi Group's 8th annual Parallel Trade conferenceSMi Group's 8th annual Parallel Trade conference
SMi Group's 8th annual Parallel Trade conference
 
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation  Immunotherapy Europe - The Perfect Combination of Strategy and Innovation
Immunotherapy Europe - The Perfect Combination of Strategy and Innovation
 
Pharma compliance EU 2015
Pharma compliance EU 2015Pharma compliance EU 2015
Pharma compliance EU 2015
 
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIESSUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
SUI GENERIS PROTECTION FOR PHARMACEUTICALS AND ITS IMPACT ON GENERIC COMPANIES
 
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
Med Knowledge Imp to Sales Team - Role of Med. Aff. Speaker Dr. KK 2023 10 03...
 
European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016European pharmacovigilance and clinical trials 2016
European pharmacovigilance and clinical trials 2016
 
European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016European pharmacovigilance and_clinical_trials_2016
European pharmacovigilance and_clinical_trials_2016
 
Product information for medicinal products in the eu
Product information for medicinal products in the euProduct information for medicinal products in the eu
Product information for medicinal products in the eu
 
SMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conferenceSMi Group's 7th annual Biosimilars Europe 2016 conference
SMi Group's 7th annual Biosimilars Europe 2016 conference
 
ICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIESICH GUIDELINE SPECIFIC WITH Q SERIES
ICH GUIDELINE SPECIFIC WITH Q SERIES
 
Responsible practice in e vapour products (evp) product stewardship 2016
Responsible practice in e vapour products (evp) product stewardship 2016Responsible practice in e vapour products (evp) product stewardship 2016
Responsible practice in e vapour products (evp) product stewardship 2016
 
PIL January First Issue 2015
PIL January First Issue 2015PIL January First Issue 2015
PIL January First Issue 2015
 

Más de MeTApresents

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reportingMeTApresents
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The PhilippinesMeTApresents
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTApresents
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And MilestonesMeTApresents
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core PrinciplesMeTApresents
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosureMeTApresents
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTApresents
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in ZambiaMeTApresents
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTApresents
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTApresents
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTApresents
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processesMeTApresents
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in JordanMeTApresents
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestonesMeTApresents
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTApresents
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in GhanaMeTApresents
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanMeTApresents
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and futureMeTApresents
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance noteMeTApresents
 

Más de MeTApresents (20)

MeTA financial systems and reporting
MeTA financial systems and reportingMeTA financial systems and reporting
MeTA financial systems and reporting
 
Priorities and milestones – The Philippines
Priorities and milestones – The PhilippinesPriorities and milestones – The Philippines
Priorities and milestones – The Philippines
 
MeTA priorities and milestones in Peru
MeTA priorities and milestones in PeruMeTA priorities and milestones in Peru
MeTA priorities and milestones in Peru
 
Jordan National Priorities And Milestones
Jordan National Priorities And MilestonesJordan National Priorities And Milestones
Jordan National Priorities And Milestones
 
MeTA introduction
MeTA introductionMeTA introduction
MeTA introduction
 
MeTA Core Principles
MeTA Core PrinciplesMeTA Core Principles
MeTA Core Principles
 
MeTA and data disclosure
MeTA and data disclosureMeTA and data disclosure
MeTA and data disclosure
 
MeTA priorities and milestones in Zambia
MeTA priorities and milestones in ZambiaMeTA priorities and milestones in Zambia
MeTA priorities and milestones in Zambia
 
Data disclosure in Zambia
Data disclosure in ZambiaData disclosure in Zambia
Data disclosure in Zambia
 
MeTA priorities and milestones in Uganda
MeTA priorities and milestones in UgandaMeTA priorities and milestones in Uganda
MeTA priorities and milestones in Uganda
 
MeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reportingMeTA programme implementation, monitoring and reporting
MeTA programme implementation, monitoring and reporting
 
MeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendationsMeTA pilot countries support needs and recommendations
MeTA pilot countries support needs and recommendations
 
Strengthening multi-stakeholder processes
Strengthening multi-stakeholder processesStrengthening multi-stakeholder processes
Strengthening multi-stakeholder processes
 
Data disclosure in Jordan
Data disclosure in JordanData disclosure in Jordan
Data disclosure in Jordan
 
MeTA International priorities and milestones
MeTA International priorities and milestonesMeTA International priorities and milestones
MeTA International priorities and milestones
 
MeTA priorities and milestones in Ghana
MeTA priorities and milestones in GhanaMeTA priorities and milestones in Ghana
MeTA priorities and milestones in Ghana
 
Data disclosure in Ghana
Data disclosure in GhanaData disclosure in Ghana
Data disclosure in Ghana
 
Data disclosurein Kyrgyzstan
Data disclosurein KyrgyzstanData disclosurein Kyrgyzstan
Data disclosurein Kyrgyzstan
 
MeTA evaluation and future
MeTA evaluation and futureMeTA evaluation and future
MeTA evaluation and future
 
MeTA country guidance note
MeTA country guidance noteMeTA country guidance note
MeTA country guidance note
 

Último

Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDr.shiva sai vemula
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Anjali Parmar
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionGolden Helix
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgeryKafrELShiekh University
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerSherrylee83
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...marcuskenyatta275
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)Monika Kanwar
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...marcuskenyatta275
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examJunhao Koh
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthCatherine Liao
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationMedicoseAcademics
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Catherine Liao
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghanahealthwatchghana
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Dr. Aryan (Anish Dhakal)
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumassuser144901
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFShahid Hussain
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenRaju678948
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxdrtabassum4
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryDr Simran Deepak Vangani
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCatherine Liao
 

Último (20)

Denture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of actionDenture base resins materials and its mechanism of action
Denture base resins materials and its mechanism of action
 
Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)Integrated Neuromuscular Inhibition Technique (INIT)
Integrated Neuromuscular Inhibition Technique (INIT)
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best supplerCas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
Cas 28578-16-7 PMK ethyl glycidate ( new PMK powder) best suppler
 
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
TEST BANK For Huether and McCance's Understanding Pathophysiology, Canadian 2...
 
In-service education (Nursing Mangement)
In-service education (Nursing Mangement)In-service education (Nursing Mangement)
In-service education (Nursing Mangement)
 
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
TEST BANK for The Nursing Assistant Acute, Subacute, and Long-Term Care, 6th ...
 
Tips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES examTips and tricks to pass the cardiovascular station for PACES exam
Tips and tricks to pass the cardiovascular station for PACES exam
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Circulation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulationCirculation through Special Regions -characteristics and regulation
Circulation through Special Regions -characteristics and regulation
 
Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...Scientificity and feasibility study of non-invasive central arterial pressure...
Scientificity and feasibility study of non-invasive central arterial pressure...
 
180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana180-hour Power Capsules For Men In Ghana
180-hour Power Capsules For Men In Ghana
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDFNCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
NCLEX RN REVIEW EXAM CONTENT BLUE BOOK PDF
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptxPT MANAGEMENT OF URINARY INCONTINENCE.pptx
PT MANAGEMENT OF URINARY INCONTINENCE.pptx
 
Factors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric DentistryFactors Affecting child behavior in Pediatric Dentistry
Factors Affecting child behavior in Pediatric Dentistry
 
Compare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from homeCompare home pulse pressure components collected directly from home
Compare home pulse pressure components collected directly from home
 

MeTA FIP workshop programme

  • 1. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice A workshop co-organised by MeTA (Medicine Transparence Aliance) and FIP FIP-WHO META Istanbul, Turkey September 5, 2009
  • 2. FIP-WHO META Istanbul, Turkey September 5, 2009 Workshop objectives: 1. To inform FIP and interested Congress participants about the Medicines Transparency Alliance (MeTA) and its concept of transparency. 2. To discuss how transparency can be applied in pharmacy practice, especially in developing countries. 3. To strengthen professional links between MeTA and FIP.
  • 3.
  • 4. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice GROUP AND PLENARY DISCUSSION FIP-WHO META Istanbul, Turkey September 5, 2009
  • 5.
  • 6.
  • 7.
  • 8.
  • 9. 69th FIP Congress, Istanbul, September 2009 Improving access to medicines: Transparency and Pharmaceutical Practice Panel Discussion FIP-WHO META Istanbul, Turkey September 5, 2009
  • 10.

Notas del editor

  1. Title of presentation 17/09/09 MeTA
  2. Title of presentation 17/09/09 MeTA
  3. Title of presentation 17/09/09 MeTA
  4. Title of presentation 17/09/09 MeTA
  5. Title of presentation 17/09/09 MeTA
  6. Title of presentation 17/09/09 MeTA
  7. Title of presentation 17/09/09 MeTA
  8. Title of presentation 17/09/09 MeTA
  9. Title of presentation 17/09/09 MeTA
  10. Title of presentation 17/09/09 MeTA